Mass Spectrometry is an analytical science with applications in the multiple fields of chemistry, physics and biology. Since its conception, it has had a very strong impact in the field of proteomics.
The world of clinical proteomics is a complex area which has been entered by several companies already. However, none of the proposed solutions have yet reached the ultimate goal of:
Producing the perfect software suite for clinicians and the right instrument for the challenge of ultimate biomarker discovery.
The Euro-MALDI project aims at developing a new powerful proteomic solution for clinical applications through the collaboration between Aix-Marseille University (Marseille, France) and Kratos Analytical Ltd. (Manchester, UK), part of the Shimadzu Corporation.
The project is based on three pillars: